LCM
OPRX icon

Laurion Capital Management’s OptimizeRx OPRX Stock Holding History

Laurion Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,000
Closed -$1.03M – 692
2021
Q3 		$1.03M Buy
+12,000
New +$753K ﹤0.01% 510

Other funds holding OPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Laurion Capital Management's OPRX Position: Q4 2021 in Review

Laurion Capital Management sold out of OptimizeRx (OPRX) in Q4 2021, closing a stake of 12,000 shares — an estimated $1.03M sold.

Laurion Capital Management first reported a position in OPRX in Q3 2021 and held it in 1 quarter. The position peaked at $1.03M in Q3 2021. 180 funds tracked by Wall St. Rank hold OPRX as of Q4 2021.

  • Laurion Capital Management reported no remaining OptimizeRx position as of Q4 2021 after selling out during the quarter.
  • Laurion Capital Management sold 12,000 OptimizeRx shares in Q4 2021, an estimated $1.03M.
  • Laurion Capital Management first reported a position in OptimizeRx in Q3 2021 and held it in 1 quarter.
  • Laurion Capital Management's OptimizeRx position peaked at $1.03M in Q3 2021.
  • 180 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2021.

Based on Laurion Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.